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In 1865, Armand Trousseau1 first characterized the 
association of thromboembolic events and malignancy. 
Then, in 1888, Ziegler2 identified vegetation in the 
cardiac valves, but this time they were associated with 
chronic inflammatory states. In 1920, Dr. Emanuel 
Libman recognized a subset of endocarditis, which 
he could not categorize according to the available 
classification, due to the lack of an apparent cause.3 
Four years later, he and Dr. Benjamin Sacks2 published 
four cases of a peculiar valvular and mural cardiac 
vegetating lesion, which was examined clinically and 
during the postmortem examination, and proved to 
be free from demonstrable microorganisms that were 
first designated as “atypical verrucous endocarditis.”4 
At that time, Libman and Sacks5 included this kind 
of endocarditis in the group of “indeterminate 
endocarditis,” which also included the so-called 
“terminal” or “cachectic” endocarditis. Originally 
Figure 1. A- Gross view of the three-leaflet aortic valve showing calcific aortic stenosis and vegetation (arrow) 
measuring 9 × 6 mm attached to the ventricular surface of the one of the aortic cusps. Note the calcium 
nodules recovered by lipid deposits projecting outwards to the aortic surface and the thickened aortic leaflets; 
B- Histopathology of the vegetation (asterisk) disclosed fibrin with no inflammatory cells; the histochemical search 
for bacteria and fungi was negative.
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described as valvular masses (mulberry-like clusters 
of verrucae) mostly involving the mitral and aortic 
valves, accompanied by leaflet thickening and valvular 
dysfunction—frequently stenosis—this entity was 
later named marantic (from the Greek—marantikos—
which means “wasting away” due to the wasting 
state of most of the patients), and in 1936 Gross and 
Friedberg6 named the lesion non-bacterial thrombotic 
endocarditis (NBTE). However, considering the negative 
results in the pursuit of all infective agents, the 
lesion is more appropriately named “non-infectious 
thrombotic endocarditis.” Since the first descriptions, 
NBTE has been associated with malignancy, chronic 
inflammatory states (e.g. infectious diseases and 
autoimmune disorders), and, more recently, sepsis 
and burns.6-12 The entity has been reported in a wide 
range of age, with no sex predilection. It involves any 
cardiac valve, but predominates in the aortic followed 
by the mitral valve.13 Vegetations generally are found 
in previously healthy valves and vary in size from 
microscopic to large, which can detach and cause 
distant infarctions. They occur characteristically in the 
coaptation edge of the leaflets and are constituted 
by degenerating platelets intermingled with fibrin. 
The local inflammatory response is feeble, which 
can explain the high frequency (average 42%) of 
detachment and embolization.7,13 The above figure 
also depicts the calcific aortic stenosis (CAS), indeed, 
the most common cause of aortic stenosis worldwide, 
and the second most frequent cardiovascular disease 
after coronary artery disease and hypertension. 
The prevalence of CAS is 0.4% in the general 
population and 1.7% among those over 65 years. 
In addition to age, the congenital abnormality 
(bicuspid valve), metabolic syndrome, and elevated 
plasma level of lipoprotein are risk factors for the 
development of CAS. Nearly half of the aortic valves 
that are surgically removed due to CAS, are bicuspid. 
This entity represents a progressive remodeling of 
the native valvular tissue into fibro-calcification. 
Initially, the valve becomes thickened or sclerotic 
(without hemodynamic derangement) but gradually 
over the years, the calcification superimposes, 
causing obstruction to the blood flow. Instead of 
a degenerative process, as previously considered, 
current histopathologic and clinical data suggest an 
active process involving lipoprotein deposition, chronic 
inflammation, osteoblastic transition of the valve 
interstitial cells, and active leaflet calcification.14
The above image refers to an autopsied case of 
a 66-year-old woman hospitalized due to marked 
asthenia, dyspnea, edema, and jaundice. She had a past 
medical history of hypertension and hypothyroidism, 
and recently she had been diagnosed with a combined 
lesion of the aortic valve (predominantly stenosis) 
and heart failure. A laboratory work-up revealed a 
peak systolic pressure gradient across the aortic valve 
of 110 mm Hg, concentric ventricular hypertrophy, 
and a mobile and filamentary vegetation attached 
to the atrial surface of the mitral valve measuring 
15 × 10 mm, elevated bilirubin, hepatic enzymes, and 
altered coagulation tests. The patient was screened for 
viral hepatitis and autoantibodies, which resulted in a 
positive ANA titer 1/320 speckled pattern. The patient 
was referred to a tertiary cardiology center with the 
working diagnosis of infective endocarditis. Blood 
cultures were repeatedly negative. The outcome was 
unfavorable with worsening of the respiratory function 
then death.
The autopsy showed an extensive venous 
thrombosis of the right iliac vein accompanied by 
great vessel pulmonary embolism with extensive 
infarction areas. The authors infer the possibility of 
a thrombophilia associated with an indeterminate 
autoimmune disease, which could explain the 
thromboembolic phenomena and the presence of 
NBTE. It is possible that the mitral valve’s vegetation 
detected on the Doppler examination detached by the 
time the autopsy was done and could not be found.
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